{"id":"https://openalex.org/W2366293709","doi":null,"title":"Synthesis of chiglitazar, a new insulin sensitizer","display_name":"Synthesis of chiglitazar, a new insulin sensitizer","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2366293709","mag":"2366293709"},"language":"en","primary_location":{"id":"mag:2366293709","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-ZXYZ200408015.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764576346","display_name":"Chinese New Drugs Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese New Drugs Journal","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100351565","display_name":"Zhibin Li","orcid":"https://orcid.org/0000-0003-4752-5528","observed_orcids":["https://orcid.org/0000-0003-4752-5528","https://orcid.org/0000-0001-5849-6334"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhibin Li","raw_affiliation_strings":["Chipscreen Biosciences Ltd"],"raw_orcid":"https://orcid.org/0000-0003-4752-5528","affiliations":[{"raw_affiliation_string":"Chipscreen Biosciences Ltd","institution_ids":["https://openalex.org/I4387155163"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100351565"],"corresponding_institution_ids":["https://openalex.org/I4387155163"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.2415612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7919999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7919999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.029999999329447746,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chiglitazar","display_name":"chiglitazar","score":1.0},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.9850000143051147},{"id":"https://openalex.org/keywords/total-synthesis","display_name":"total synthesis","score":0.7559999823570251},{"id":"https://openalex.org/keywords/ethylene-dibromide","display_name":"1,2-dibromoethane","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C134121241","wikidata":"https://www.wikidata.org/wiki/Q899301","display_name":"Yield (engineering)","level":2,"score":0.7209791541099548},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6533740162849426},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6279578804969788},{"id":"https://openalex.org/C90150868","wikidata":"https://www.wikidata.org/wiki/Q39513","display_name":"Alkoxy group","level":3,"score":0.4860439896583557},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.3743640184402466},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.36230796575546265},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3566315472126007},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2973673343658447},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11768794059753418},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08100661635398865},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.06700912117958069},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.0},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2366293709","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-ZXYZ200408015.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764576346","display_name":"Chinese New Drugs Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese New Drugs Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1969322259","https://openalex.org/W2951245522","https://openalex.org/W7052911497","https://openalex.org/W2074908909","https://openalex.org/W2373675037","https://openalex.org/W2076202675","https://openalex.org/W2951037228","https://openalex.org/W2376636986","https://openalex.org/W1978116336","https://openalex.org/W2038330923"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"synthesize":[2],"chiglitazar,":[3],"(2S)-2-[2-(4-fluorobenzoyl)":[4],"phenylamine]-3-[4-(2-carbazol-9-yl-ethoxy)-phenyl]-propionic":[5],"acid,a":[6],"new":[7],"insulin":[8],"sensitizer.":[9],"Methods:Chiglitazar":[10],"was":[11,30],"synthesized":[12],"from":[13],"2-(4-fluoro)benzoylcyclohexanone,":[14],"L-tyrosine":[15],"methyl":[16],"ester":[17],"and":[18,35],"1,2-dibromoethane":[19],"via":[20],"3":[21],"steps.":[22],"Results:":[23],"A":[24,33],"total":[25],"yield":[26],"of":[27,41],"10.":[28],"8%":[29],"obtained.":[31],"Conclusion:":[32],"short":[34],"easily":[36],"controlled":[37],"process":[38],"for":[39],"synthesis":[40],"chiglitazar":[42],"is":[43],"established.":[44]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}